1. Academic Validation
  2. Identification of a novel compound heterozygote SCO2 mutation in cytochrome c oxidase deficient fatal infantile cardioencephalomyopathy

Identification of a novel compound heterozygote SCO2 mutation in cytochrome c oxidase deficient fatal infantile cardioencephalomyopathy

  • Acta Paediatr. 2007 Jan;96(1):130-2. doi: 10.1111/j.1651-2227.2007.00008.x.
M Knuf 1 J Faber R G Huth P Freisinger F Zepp C Kampmann
Affiliations

Affiliation

  • 1 Children's Hospital, Johannes Gutenberg-University, Mainz, Germany.
Abstract

Fatal infantile cardioencephalomyopathy (OMIM No. 604377) is a disorder of the mitochondrial respiratory chain and is characterised by neonatal progressive muscular hypotonia and cardiomyopathy because of severe Cytochrome c oxidase deficiency. Here we report a novel mutation in the Cytochrome c oxidase assembly gene SCO2 in an infant with fatal infantile cardioencephalomyopathy despite normal initial metabolic screening.

Conclusion: In newborns with unexplained muscular hypotonia and cardiomyopathy genetic testing of mitochondrial respiratory chain disorders might be helpful to establish a final diagnosis and guide treatment decisions.

Figures